Cancer

Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer

New CCO Joins as Cytosurge Engages in Key Scientific Events Across the USA and BeyondZURICH, Switzerland, April 09, 2025 (GLOBE…

9 months ago

Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs

WARREN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company…

9 months ago

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort

-Phio's lead clinical siRNA compound PH-762 demonstrates supportive safety profile in third cohort, permitting escalation in next dose concentrationMarlborough, Massachusetts--(Newsfile…

9 months ago

Major Cost Savings on Top Cancer Drugs with India-Approved Alternatives

Patients Can Save Thousands on Life-Saving Oncology Medications by Accessing Safe, Affordable Options says SaveRxCanada.to VANCOUVER, BC, April 9, 2025…

9 months ago

Sport Clips Haircuts Continues to Shave the Way for Childhood Cancer Research with $1 Million Pledge

Los Angeles, California--(Newsfile Corp. - April 8, 2025) - Sport Clips Haircuts continues to lead in corporate social responsibility focused…

9 months ago

ShiftMed and Powers Health Partner to Strengthen Healthcare Workforce

Powers Health is the first health system in Indiana to deliver On-Demand nursing support and work opportunities for local nurses…

9 months ago

Freenome Names Aaron Elliott, Ph.D., as Chief Executive Officer to Lead the Company’s Next Chapter of Commercial Growth and Product Innovation

Accomplished industry leader brings specialized experience to advance Freenome's screening blood tests for colorectal cancer, lung cancer and additional indications…

9 months ago

Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia

New partnership strengthens Psyence BioMed's global clinical trial capabilities, accelerating the development of psilocybin-assisted therapy for adjustment disorderNew York, New…

9 months ago

SHINE and Sumitomo Corporation of Americas Announce Partnership to Expand Medical Isotope and Fusion Technology Distribution in Asian Markets

Strategic alliance set to strengthen supply chains for medical isotopes, industrial applications, and fusion technologies between North America and Asia,…

9 months ago

Defence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies

Montreal, Quebec--(Newsfile Corp. - April 8, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"),…

9 months ago